ENVB Enveric Biosciences, Inc.
$1.42▼ -2.74%
Healthcare
Other
After hours
$1.38▼ -2.52%
Sep 11, 7:32 PM ET
Volume 37.8K
Avg Volume (10D) 33.4K
Key Metrics & Fundamentals
Market Cap
$6.36M
P/E Ratio
–
Div Yield
–%
52W Range
1.17 - 13.25
% vs 50 MA
-0.32%
% vs 200 MA
-46.52%
RSI-14
48.4
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.41
Free Cash Flow
-$2.44M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.99M
COGS
–
Operating Exp
$3.03M
Operating Income
-$3.03M
EBIT
-$3.03M
Pretax Income
-$3.03M
Net Income
-$3.03M
EPS (Diluted)
-0.76
Price & Volume History
Loading chart…
Recent News
Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference
Business Wire · Sep 1, 2026 12:30 PM
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026
Business Wire · Aug 14, 2026 8:05 PM
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003
Business Wire · Aug 5, 2026 12:00 PM
Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development
Business Wire · Jul 28, 2026 12:00 PM
Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
Business Wire · Jun 29, 2026 12:00 PM
Enveric Biosciences Announces Participation in 2026 BIO International Convention
Business Wire · Jun 16, 2026 1:28 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ENVB's money flow as a full page
Social Sentiment
No Reddit posts found for ENVB.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.